FOR RESEARCH USE ONLY.
Vials：1ml：xxμg / 1ml：xxμg
Indications and Usage:
A. Shortening or normalisation of prolonged bleeding time prior to an invasive therapeutic or diagnostic operation, or for therapeutic control of bleeding in patients with prolonged bleeding time as a consequence of congenital or substance-
B. For the therapeutic control of bleeding and bleeding prophylaxis in connection with minor surgical procedures in patients with mild haemophilia A and von Willebrand’s disease who respond positively to a test dose. In exceptional cases, even moderate forms of the disease can be treated. MINIRIN must not be used in patients with von Willebrand’s disease type IIB.
C. Treatment of central diabetes insipidus and for establishing renal concentration capacity testing.
If the intranasal presentation is not available (do not use for children) , desmopressin acetate for injection can be used. Dose adjusted according to patient’s urine volume and urine osmotic pressure.
Normal dose by intramuscular injection: Adults x-
C. Kidney urine concentration test
Normal dose by intramuscular or subcutaneous injection: Adults 4µg (1ml), for children above the age of 1 year, x-